(Q40423779)

20 September 2017

1 reference

title

Treatment of colorectal cancer metastases confined to the liver (English)

1 reference

20 September 2017

1 reference

1 reference

van de Velde CJ

3

1 reference

20 September 2017

A. L. Vahrmeijer

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7577030

19 May 2024

J. H. van Dierendonck

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7577030

19 May 2024

C. J. van de Velde

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7577030

19 May 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7577030

19 May 2024

publication date

1 July 1995

1 reference

full work available at URL

20 September 2017

https://api.elsevier.com/content/article/PII:0959804995002144?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)00214-4

https://api.elsevier.com/content/article/PII:0959804995002144?httpAccept=text/plain

19 May 2024

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)00214-4

European Journal of Cancer

19 May 2024

published in

1 reference

20 September 2017

31A

1 reference

20 September 2017

7-8

1 reference

20 September 2017

1238-1242

1 reference

Surgical management of patients with primary operable colorectal cancer and synchronous liver metastases

20 September 2017

1

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)00214-4

The clinical correlation of an autopsy study of recurrent colorectal cancer

19 May 2024

2

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)00214-4

The natural history of hepatic metastases from colorectal cancer. A comparison with resective treatment.

19 May 2024

3

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)00214-4

A retrospective study of the natural history of patients with liver metastases from colorectal cancer

19 May 2024

4

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)00214-4

Chemotherapy of large bowel cancer

19 May 2024

5

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)00214-4

Hepatic resection for colorectal liver metastases. Influence on survival of preoperative factors and surgery for recurrences in 80 patients

19 May 2024

6

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)00214-4

Hepatic resections for colorectal metastases in The Netherlands. A multiinstitutional 10-year study

19 May 2024

8

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)00214-4

Hepatic metastases from colorectal carcinoma: impact of surgical resection on the natural history

19 May 2024

9

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)00214-4

Resection of hepatic metastases from colorectal cancer

19 May 2024

11

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)00214-4

Determinants of survival in liver resection for colorectal secondaries

19 May 2024

12

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)00214-4

One hundred patients with hepatic metastases from colorectal cancer treated by resection: analysis of prognostic determinants

19 May 2024

13

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)00214-4

Survival benefit of repeat liver resections for recurrent colorectal metastases: 143 cases. Association Francaise de Chirurgie

19 May 2024

16

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)00214-4

A randomized controlled trial of adjuvant portal vein cytotoxic perfusion in colorectal cancer

19 May 2024

17

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)00214-4

Phase II study of hepatic arterial floxuridine, leucovorin, and dexamethasone for unresectable liver metastases from colorectal carcinoma

19 May 2024

18

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)00214-4

Tumor and liver drug uptake following hepatic artery and portal vein infusion

19 May 2024

20

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)00214-4

Regional chemotherapy of colorectal cancer metastatic to the liver

19 May 2024

21

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)00214-4

Hepatic artery pump infusion: toxicity and results in patients with metastatic colorectal carcinoma

19 May 2024

23

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)00214-4

Therapy for metastatic colorectal cancer with hepatic artery infusion chemotherapy using a subcutaneous implanted pump.

19 May 2024

24

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)00214-4

Randomized trial of hepatic arterial floxuridine, mitomycin, and carmustine versus floxuridine alone in previously treated patients with liver metastases from colorectal cancer

19 May 2024

25

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)00214-4

Intrahepatic or systemic infusion of fluorodeoxyuridine in patients with liver metastases from colorectal carcinoma. A randomized trial

19 May 2024

26

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)00214-4

Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: long-term results of a prospective randomized trial

19 May 2024

28

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)00214-4

A prospective randomized trial of regional versus systemic continuous 5-fluorodeoxyuridine chemotherapy in the treatment of colorectal liver metastases

19 May 2024

29

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)00214-4

Intra-arterial floxuridine vs systemic fluorouracil for hepatic metastases from colorectal cancer. A randomized trial

19 May 2024

30

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)00214-4

A successful technique of in vivo isolated liver perfusion in pigs

19 May 2024

33

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)00214-4

Phase II trial of high-dose melphalan and autologous bone marrow transplantation for metastatic colon carcinoma

19 May 2024

34

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)00214-4

Cellular pharmacokinetics of the phenylalanine mustards

19 May 2024

35

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)00214-4

In vivo therapeutic potential of combination thiol depletion and alkylating chemotherapy

19 May 2024

36

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)00214-4

Depletion of tumour versus normal tissue glutathione by buthionine sulfoximine

19 May 2024

37

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)00214-4

Influence of dearterialization on distribution of absolute tumor blood flow between hepatic artery and portal vein

19 May 2024

38

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)00214-4

Oxidative stress as a mediator of apoptosis

19 May 2024

39

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)00214-4

Glutathione S-transferases in liver metastases of colorectal cancer. A comparison with normal liver and primary carcinomas.

19 May 2024

40

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)00214-4

Glutathione-S-transferase activates novel alkylating agents

19 May 2024

42

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)00214-4

In Vivo Gene Transfer with Retroviral Vector-Producer Cells for Treatment of Experimental Brain Tumors

19 May 2024

43

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)00214-4

19 May 2024

Identifiers

1 reference

20 September 2017

1 reference